The global veterinary oncology market size was valued at USD 1.35 billion in 2025 and is projected to grow from USD 1.49 billion in 2026 to USD 3.34 billion by 2034 at a CAGR of 10.6% during the forecast period 2026-2034. North America dominated the veterinary oncology market with a market share of 42.5% in 2025.
Veterinary oncology is the branch of veterinary medicine focused on the prevention, diagnosis, treatment, and management of cancer in animals. It involves advanced techniques such as imaging, biopsy, surgery, chemotherapy, radiation therapy, and immunotherapy to treat various types of tumors. Veterinary oncology helps improve survival rates, manage symptoms, and enhance the quality of life of companion animals and other veterinary patients.
Download a Free Sample To learn more about this report,
Growing Development of Targeted Cancer Therapies for Companion Animals
The veterinary oncology market trends are increasingly moving toward targeted treatments, monoclonal antibodies, cancer vaccines, and therapies designed specifically for dogs and cats. Cancer is a major health concern in companion animals; Zoetis reports that about 1 in 4 dogs in North America develop cancer during their lifetime, with the proportion rising to about 50% among dogs over 10 years old. This growing clinical need is encouraging pharmaceutical companies to develop treatments that can provide better disease control while maintaining quality of life.
Rising Focus on Earlier Diagnosis and Personalized Veterinary Cancer Care
The veterinary oncology market is also benefiting from improvements in diagnostic imaging, biomarkers, and molecular testing. Veterinarians are increasingly using these tools to identify tumors earlier and select treatments according to cancer type and disease stage. The FDA's veterinary cancer guidance notes that animal-specific cancer medicines have expanded considerably in recent years.
Rising Prevalence of Cancer in Companion Animals and Advancing Veterinary Care
The veterinary oncology market growth is primarily driven by increasing cancer incidence among ageing companion animals and greater awareness of veterinary cancer diagnosis and treatment. Dogs and cats are living longer due to improved nutrition, preventive care, and veterinary services, increasing the likelihood of age-related diseases such as lymphoma, mast cell tumors, mammary tumors, and osteosarcoma. Growing pet ownership and rising expenditure on advanced animal healthcare are further supporting demand for oncology services. The veterinary oncology market growth is also supported by improved diagnostic imaging, pathology, chemotherapy, radiation therapy, immunotherapy, and targeted treatments that provide veterinarians with more options for managing complex cancers.
High Treatment Costs and Limited Access to Specialized Oncology Services
The veterinary oncology market faces significant restraints due to the high cost of advanced diagnostic procedures, chemotherapy, radiation therapy, and specialized veterinary care. Treatment expenses can be difficult for pet owners to manage, particularly when multiple treatment cycles or long-term monitoring are required. The veterinary oncology market analysis also indicates that specialized oncology hospitals, veterinary oncologists, advanced imaging facilities, and radiation treatment centers remain concentrated in major urban markets. Limited pet insurance coverage for cancer treatment further restricts access. In addition, concerns regarding treatment side effects and uncertain outcomes can influence owners' decisions about pursuing intensive cancer therapy.
Expansion of Targeted Therapies and Companion Animal Cancer Research
The increasing development of targeted therapies, immunotherapies, and personalized veterinary medicine is creating significant opportunities for the veterinary oncology market. Advances in molecular diagnostics are helping veterinarians identify tumor characteristics and select more appropriate treatment strategies for individual animals. The veterinary oncology market analysis highlights growing research into cancer vaccines, monoclonal antibodies, precision diagnostics, and novel drug-delivery technologies. Increasing collaborations between veterinary hospitals, pharmaceutical companies, and research institutions are also expanding the therapeutic pipeline. Rising demand for specialized pet healthcare and improved access to advanced diagnostic technologies are expected to create substantial long-term opportunities.
Limited Clinical Data and Complex Treatment Decisions
One of the major challenges facing the veterinary oncology market is the limited availability of large-scale clinical evidence for many emerging cancer therapies compared with human oncology. Differences among animal species, breeds, tumor types, and individual responses make treatment development and clinical evaluation complex. The veterinary oncology market growth is also affected by regulatory requirements, shortages of specialized veterinary oncologists, high research costs, and difficulties conducting sufficiently large clinical studies. In addition, treatment decisions must consider quality of life, prognosis, affordability, and owner preferences. Balancing therapeutic innovation with evidence-based care and accessibility remains a key challenge for market participants.
Request Customizationto receive a tailored report.
Surgery Dominated the Market with 29.6% Share in 2025
The surgery segment accounted for the largest share of the global veterinary oncology market at 29.6% in 2025, driven by the widespread use of surgical tumor removal as a primary treatment approach for localized cancers in companion animals.
Targeted therapy is projected to register the fastest growth at a CAGR of 13.8% during 2026–2034, supported by increasing advances in precision veterinary medicine, improved understanding of tumor biology, and growing demand for therapies designed to selectively target cancer cells. Immunotherapy is also witnessing strong adoption as veterinary oncology advances toward more personalized treatment approaches. Chemotherapy remains an important treatment option for systemic and metastatic cancers, while radiology continues to support diagnosis, treatment planning, and cancer management. Other therapies contribute to the market through specialized treatment approaches.
Canine Dominated the Market with 63.4% Share in 2025
The canine segment accounted for the largest share of the global veterinary oncology market at 63.4% in 2025, driven by the high prevalence of cancer among dogs, increasing pet ownership, greater awareness of veterinary cancer care, and improved access to specialized oncology services.
The feline segment continues to witness steady demand as pet owners increasingly seek advanced diagnostic and therapeutic options for cancer treatment. Other animal types also contribute to market growth as veterinary oncology services expand beyond traditional companion animals and specialized treatment capabilities become more accessible.
Lymphoma Dominated the Market with 32.6% Share in 2025
The lymphoma segment accounted for the largest share of the global veterinary oncology market at 32.6% in 2025, driven by the relatively high occurrence of lymphoma in companion animals and the availability of established diagnostic and treatment protocols.
Mast cell cancer remains a major cancer type in veterinary oncology, particularly among dogs, while mammary and squamous cell cancers continue to generate significant treatment demand. Other cancer types are also contributing to market growth as diagnostic technologies improve and veterinary specialists increasingly identify and treat a broader range of tumors.
Speak to an Analystto discuss market opportunities.
North America market accounted for 42.5% of the global veterinary oncology market, valued at USD 0.57 billion in 2025. The region's leadership is driven by increasing pet ownership, rising awareness of companion animal cancer treatment, growing veterinary healthcare expenditure, and expanding availability of advanced diagnostic and therapeutic options. Increasing adoption of specialty veterinary care and continuous advancements in veterinary oncology continue to support regional market growth.
The United States market accounted for the largest share of the North American market in 2025. Growth is driven by increasing pet healthcare spending, rising incidence of cancer among companion animals, expanding availability of veterinary specialty hospitals, and growing adoption of chemotherapy, radiation therapy, and targeted treatments. Strong veterinary research capabilities further strengthen the country's market position.
Canada market is witnessing steady market growth due to increasing pet ownership, rising spending on veterinary healthcare, expanding access to specialized oncology services, and growing adoption of advanced cancer diagnostics and treatment options for companion animals.
Europe market accounted for 27.8% of the global veterinary oncology market, reaching USD 0.38 billion in 2025, and is projected to register the fastest CAGR of 12.4% during the forecast period. Market growth is supported by increasing pet healthcare expenditure, growing awareness of animal cancer treatment, expanding veterinary specialty services, and rising adoption of advanced diagnostic and therapeutic technologies. Continuous improvements in veterinary healthcare infrastructure continue to drive regional demand.
The United Kingdom market is witnessing steady market growth owing to increasing pet healthcare spending, expanding access to veterinary oncology specialists, rising adoption of advanced cancer diagnostics, and growing demand for specialized treatment options.
Germany market represents one of the largest markets in Europe, driven by advanced veterinary healthcare infrastructure, increasing adoption of cancer diagnostics and therapies, growing investments in veterinary research, and rising demand for specialized oncology services.
Asia Pacific market accounted for 18.6% of the global veterinary oncology market, valued at USD 0.25 billion in 2025. The market is expanding due to rising pet ownership, increasing awareness of animal healthcare, growing veterinary expenditure, and improving access to specialized veterinary services. Expanding veterinary hospital networks and adoption of advanced diagnostic technologies continue to support regional market growth.
Japan market is witnessing steady market growth due to increasing pet healthcare expenditure, a growing aging pet population, expanding veterinary specialty services, and rising adoption of advanced cancer diagnostic and treatment technologies.
China market accounted for the largest share of the Asia Pacific market in 2025. Growth is supported by rising pet ownership, increasing consumer spending on animal healthcare, expanding veterinary hospital infrastructure, and growing adoption of advanced oncology diagnostics and treatments.
The Middle East & Africa market represented 4.7% of the global veterinary oncology market, totaling USD 0.06 billion in 2025. Rising pet ownership, increasing awareness of companion animal healthcare, expanding veterinary infrastructure, and growing access to specialized diagnostic and treatment services are supporting regional market growth.
The UAE market is a key market in the Middle East, driven by increasing pet ownership, rising spending on premium veterinary care, expanding specialty veterinary clinics, and growing adoption of advanced diagnostic and oncology treatment technologies.
Africa market is witnessing gradual market growth, supported by increasing pet ownership, improving veterinary healthcare infrastructure, rising awareness of animal cancer treatment, and expanding access to specialized veterinary services. Countries such as South Africa, Kenya, and Nigeria are creating long-term growth opportunities for market participants.
Unlock Regional Insightsto access country-level data, & regional trends.
Customize This Report to Match Your Strategic Objectives
Author's Details
Healthcare Lead
Debashree Bora is a Healthcare Lead with over 7 years of industry experience, specializing in Healthcare IT. She provides comprehensive market insights on digital health, electronic medical records, telehealth, and healthcare analytics. Debashree’s research supports organizations in adopting technology-driven healthcare solutions, improving patient care, and achieving operational efficiency in a rapidly transforming healthcare ecosystem.
We are featured on:
sales@straitsresearch.com